Pegunigalsidase alfa
- Generic Name
- Pegunigalsidase alfa
- Brand Names
- Elfabrio
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 1644392-61-9
- Unique Ingredient Identifier
- 8M7V7Q6537
- Background
Pegunigalsidase alfa (PRX-102) is a recombinant form of human α-galactosidase-A indicated for long-term enzyme replacement therapy in patients with Fabry disease, a rare genetic disorder characterized by the deficiency of alpha-galactosidase A. Unlike other forms of recombinant alpha-galactosidase A, such as agalsidase alfa and agalsidase beta, pegunigalsida...
- Indication
Pegunigalsidase alfa is indicated for long-term enzyme replacement therapy in adult patients with a confirmed diagnosis of Fabry disease (deficiency of alpha-galactosidase).
- Associated Conditions
- Fabry's Disease
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath